Gene · 10521
NIH grants1,197
NIH grants whose papers are about the gene, through NIH's grant-paper links.
981 to 1,000 of 1,197
Download this page as JSON| Grant | Title | DDX17 papers | Newest fiscal year |
|---|---|---|---|
| R01CA037372 | Tyrosine Protein Kinases and Lymphocyte Activation | 1 | 2011 |
| R01CA041072 | Src family kinases and cell growth regulation | 1 | 2011 |
| R01CA072943 | Mechanism and Function of HECT E3s in Ubiquitin and ISG15 Conjugation | 1 | 2011 |
| R01CA093840 | Genesis of Liver Carcinomas with Oval Cell Traits | 1 | 2011 |
| R01CA118761 | p53 and pathways of apoptosis | 1 | 2011 |
| R01CA125020 | Analysis of the VHL-HIF hydroxylase pathway | 1 | 2011 |
| R01DK074842 | Genetics of Obesity in Yup'ik Eskimos | 1 | 2011 |
| R01ES011195 | Nuclear and cytoplasmic redox in oxidative stress | 1 | 2011 |
| R01ES015317 | Nuclear integration of environmental toxic signals relevant to PD | 1 | 2011 |
| R01GM079774 | Characterization of novel modifiers of dE2F/RBF function | 1 | 2011 |
| R01GM080563 | Molecular recognition and regulation in microRNA processing by the DGCR8 protein | 1 | 2011 |
| R01HD037432 | Molecular mechanism of leiomyoma growth and regression | 1 | 2011 |
| R01HL083335 | MAPK-activated protein kinase 2 regulation of endothelial cell migration | 1 | 2011 |
| R21AA020104 | Protective behavioral strategies and mental health: Reducing alcohol-related risk | 1 | 2011 |
| R21AI088424 | Molecular mechanism of innate immunity control of HBV replication | 1 | 2011 |
| R21CA152497 | Mechanism of BCL6-dependent stem cell maintenance in B cell lineage leukemia | 1 | 2011 |
| R21ES018915 | Can shift-work shift epigenetic changes? | 1 | 2011 |
| R21NS067461 | Developing therapeutic intervention for FXTAS | 1 | 2011 |
| R37NS027036 | Neurofilaments, SOD1 and Motor Neuron Diseases | 1 | 2011 |
| T32CA070089 | Laboratory Training for Clinical Oncologists | 1 | 2011 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10521/grants?page=50